Abiopharma

News list

Director KERSTEN GEERT R 🟢 acquired 300.0K shares (1 derivative) of CEL SCI CORP (CVM) at $1.49 Transaction Date: Aug 14, 2026 | Filing ID: 000007

Full text

News bot Aug. 17, 2026, 1:19 p.m.
🔍 KERSTEN GEERT R (Director)

Company: CEL SCI CORP (CVM)

Report Date: 2026-08-14
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 300,000
Detailed Transactions and Holdings:
- Acquired 300,000 shares of Options at $1.49 per share (Derivative)
  Date: 2026-08-14 | Code: A | Expires: 2036-08-13 | equity_swap_involved: 0 | shares_owned_after: 452,380.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The stock options vest in three (3) equal annual installments commencing one year after the grant date.